115 related articles for article (PubMed ID: 31919525)
1. Nasopharyngeal Microbiota Profiles in Rural Venezuelan Children Are Associated With Respiratory and Gastrointestinal Infections.
Verhagen LM; Rivera-Olivero IA; Clerc M; Chu MLJN; van Engelsdorp Gastelaars J; Kristensen MI; Berbers GAM; Hermans PWM; de Jonge MI; de Waard JH; Bogaert D
Clin Infect Dis; 2021 Jan; 72(2):212-221. PubMed ID: 31919525
[TBL] [Abstract][Full Text] [Related]
2. The association between pneumococcal vaccination, ethnicity, and the nasopharyngeal microbiota of children in Fiji.
Boelsen LK; Dunne EM; Mika M; Eggers S; Nguyen CD; Ratu FT; Russell FM; Mulholland EK; Hilty M; Satzke C
Microbiome; 2019 Jul; 7(1):106. PubMed ID: 31311598
[TBL] [Abstract][Full Text] [Related]
3. Loss of Microbial Topography between Oral and Nasopharyngeal Microbiota and Development of Respiratory Infections Early in Life.
Man WH; Clerc M; de Steenhuijsen Piters WAA; van Houten MA; Chu MLJN; Kool J; Keijser BJF; Sanders EAM; Bogaert D
Am J Respir Crit Care Med; 2019 Sep; 200(6):760-770. PubMed ID: 30883192
[No Abstract] [Full Text] [Related]
4. Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana.
Kelly MS; Surette MG; Smieja M; Rossi L; Luinstra K; Steenhoff AP; Goldfarb DM; Pernica JM; Arscott-Mills T; Boiditswe S; Mazhani T; Rawls JF; Cunningham CK; Shah SS; Feemster KA; Seed PC
Pediatr Infect Dis J; 2018 Nov; 37(11):1176-1183. PubMed ID: 30153231
[TBL] [Abstract][Full Text] [Related]
5. Maturation of the Infant Respiratory Microbiota, Environmental Drivers, and Health Consequences. A Prospective Cohort Study.
Bosch AATM; de Steenhuijsen Piters WAA; van Houten MA; Chu MLJN; Biesbroek G; Kool J; Pernet P; de Groot PCM; Eijkemans MJC; Keijser BJF; Sanders EAM; Bogaert D
Am J Respir Crit Care Med; 2017 Dec; 196(12):1582-1590. PubMed ID: 28665684
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age.
Karppinen S; Toivonen L; Schuez-Havupalo L; Teros-Jaakkola T; Waris M; Auranen K; Palmu AA; Peltola V
Vaccine; 2019 May; 37(22):2935-2941. PubMed ID: 31027929
[TBL] [Abstract][Full Text] [Related]
7. The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens.
Edouard S; Million M; Bachar D; Dubourg G; Michelle C; Ninove L; Charrel R; Raoult D
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1725-1733. PubMed ID: 30033505
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
[TBL] [Abstract][Full Text] [Related]
9. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
[TBL] [Abstract][Full Text] [Related]
10. Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case-control study.
Mika M; Maurer J; Korten I; Allemann A; Aebi S; Brugger SD; Qi W; Frey U; Latzin P; Hilty M
Microbiome; 2017 Jul; 5(1):85. PubMed ID: 28738889
[TBL] [Abstract][Full Text] [Related]
11. Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial.
Man WH; Scheltema NM; Clerc M; van Houten MA; Nibbelke EE; Achten NB; Arp K; Sanders EAM; Bont LJ; Bogaert D
Lancet Respir Med; 2020 Oct; 8(10):1022-1031. PubMed ID: 32203712
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study of the infant nasopharyngeal microbiota: The effects of age, illness and antibiotic use in a cohort of South East Asian children.
Salter SJ; Turner C; Watthanaworawit W; de Goffau MC; Wagner J; Parkhill J; Bentley SD; Goldblatt D; Nosten F; Turner P
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005975. PubMed ID: 28968382
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction.
Njuma Libwea J; Gröndahl-Yli-Hannuksela K; Kobela M; Toropainen M; Nyholm O; Ndombo PK; Koulla-Shiro S; Nohynek H; Nuorti JP; Vuopio J; Palmu AA
Int J Infect Dis; 2020 Sep; 98():113-120. PubMed ID: 32562849
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940
[TBL] [Abstract][Full Text] [Related]
15. Rapid Increase of Oral Bacteria in Nasopharyngeal Microbiota After Antibiotic Treatment in Children With Invasive Pneumococcal Disease.
Henares D; Rocafort M; Brotons P; de Sevilla MF; Mira A; Launes C; Cabrera-Rubio R; Muñoz-Almagro C
Front Cell Infect Microbiol; 2021; 11():744727. PubMed ID: 34712623
[TBL] [Abstract][Full Text] [Related]
16. Effects of 10-valent pneumococcal conjugate (PCV10) vaccination on the nasopharyngeal microbiome.
Salgado VR; Fukutani KF; Fukutani E; Lima JV; Rossi EA; Barral A; de Oliveira CI; Nascimento-Carvalho C; Van Weyenbergh J; Queiroz ATL
Vaccine; 2020 Feb; 38(6):1436-1443. PubMed ID: 31839468
[TBL] [Abstract][Full Text] [Related]
17. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.
Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM
Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
[TBL] [Abstract][Full Text] [Related]
19. The Nasopharyngeal Microbiota of Children With Respiratory Infections in Botswana.
Kelly MS; Surette MG; Smieja M; Pernica JM; Rossi L; Luinstra K; Steenhoff AP; Feemster KA; Goldfarb DM; Arscott-Mills T; Boiditswe S; Rulaganyang I; Muthoga C; Gaofiwe L; Mazhani T; Rawls JF; Cunningham CK; Shah SS; Seed PC
Pediatr Infect Dis J; 2017 Sep; 36(9):e211-e218. PubMed ID: 28399056
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal carriage of Streptococcus pneumoniae among HIV-infected and -uninfected children <5 years of age before introduction of pneumococcal conjugate vaccine in Mozambique.
Verani JR; Massora S; Acácio S; Dos Santos RT; Vubil D; Pimenta F; Moura I; Whitney CG; Costa MH; Macete E; Matsinhe MB; Carvalho MDG; Sigaúque B
PLoS One; 2018; 13(2):e0191113. PubMed ID: 29447196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
